Literature DB >> 11052219

Pre- and postsynaptic aspects of dopamine-mediated transmission.

J R Walters1, D N Ruskin, K A Allers, D A Bergstrom.   

Abstract

Dopamine agonist administration induces changes in firing rate and pattern in basal ganglia nuclei that provide an insight into the role of dopamine in basal ganglia function. These changes support a more complex, integrated basal ganglia network than envisioned in early models. Functionally important effects on basal ganglia output involve alterations in burstiness, synchronization and oscillatory activity,as well as rate. Multisecond oscillations in basal ganglia firing rates are markedly affected by systemic administration of dopamine-receptor agonists. This suggests that coordinated changes in neuronal activity at time scales longer than commonly investigated play a role in the cognitive and motor processes that are modulated by dopamine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11052219     DOI: 10.1016/s1471-1931(00)00024-0

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  14 in total

1.  Effects of prenatal exposure to methylmercury on dopamine-mediated locomotor activity and dopamine D2 receptor binding.

Authors:  Elisabetta Daré; Serguei Fetissov; Tomas Hökfelt; Håkan Hall; Sven Ove Ogren; Sandra Ceccatelli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-09       Impact factor: 3.000

Review 2.  Intrinsic and integrative properties of substantia nigra pars reticulata neurons.

Authors:  F-M Zhou; C R Lee
Journal:  Neuroscience       Date:  2011-08-02       Impact factor: 3.590

3.  The Influence of Dopamine on Cognitive Flexibility Is Mediated by Functional Connectivity in Young but Not Older Adults.

Authors:  Anne S Berry; Vyoma D Shah; William J Jagust
Journal:  J Cogn Neurosci       Date:  2018-05-23       Impact factor: 3.225

Review 4.  Mechanisms of motivation-cognition interaction: challenges and opportunities.

Authors:  Todd S Braver; Marie K Krug; Kimberly S Chiew; Wouter Kool; J Andrew Westbrook; Nathan J Clement; R Alison Adcock; Deanna M Barch; Matthew M Botvinick; Charles S Carver; Roshan Cools; Ruud Custers; Anthony Dickinson; Carol S Dweck; Ayelet Fishbach; Peter M Gollwitzer; Thomas M Hess; Derek M Isaacowitz; Mara Mather; Kou Murayama; Luiz Pessoa; Gregory R Samanez-Larkin; Leah H Somerville
Journal:  Cogn Affect Behav Neurosci       Date:  2014-06       Impact factor: 3.282

5.  Dopamine supports coupling of attention-related networks.

Authors:  Linh C Dang; James P O'Neil; William J Jagust
Journal:  J Neurosci       Date:  2012-07-11       Impact factor: 6.167

6.  D5 (not D1) dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance.

Authors:  Jérôme Baufreton; Maurice Garret; Alicia Rivera; Adélaïda de la Calle; François Gonon; Bernard Dufy; Bernard Bioulac; Anne Taupignon
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

7.  Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism.

Authors:  Gali Heimer; Izhar Bar-Gad; Joshua A Goldberg; Hagai Bergman
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

8.  Dopaminergic drug effects on physiological connectivity in a human cortico-striato-thalamic system.

Authors:  G D Honey; J Suckling; F Zelaya; C Long; C Routledge; S Jackson; V Ng; P C Fletcher; S C R Williams; J Brown; E T Bullmore
Journal:  Brain       Date:  2003-06-04       Impact factor: 13.501

9.  Movement related dynamics of subthalmo-cortical alpha connectivity in Parkinson's disease.

Authors:  Ashwini Oswal; Peter Brown; Vladimir Litvak
Journal:  Neuroimage       Date:  2012-12-28       Impact factor: 6.556

10.  Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes.

Authors:  J Elia; X Gai; H M Xie; J C Perin; E Geiger; J T Glessner; M D'arcy; R deBerardinis; E Frackelton; C Kim; F Lantieri; B M Muganga; L Wang; T Takeda; E F Rappaport; S F A Grant; W Berrettini; M Devoto; T H Shaikh; H Hakonarson; P S White
Journal:  Mol Psychiatry       Date:  2009-06-23       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.